Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Minehiko Inomata

5PUBLICATIONS

7CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Nov 04, 2025

TGFβ1 and SMAD3 Expression Are Associated With Survival After the Immune Checkpoint Inhibitor Therapy for Small Cell Lung Cancer.

Zenta Seto, Minehiko Inomata, Akira Noguchi

|Apr 26, 2023

Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.

Minehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa

|Dec 01, 2021

Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer.

Zenta Seto, Naoki Takata, Nozomu Murayama

|Dec 01, 2020

Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy.

Minehiko Inomata, Kenji Azechi, Naoki Takata

|Sep 21, 2018

Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy.

Minehiko Inomata, Takahiro Hirai, Zenta Seto

Pageof 1

Frequent Collaborators

3 joint publications

Ryuji Hayashi

1 joint publications

Shoko Matsui

1 joint publications

Akira Noguchi

1 joint publications

Tomonobu Kado

1 joint publications

Seisuke Okazawa

1 joint publications

Kenichi Hirabayashi

1 joint publications

Kazuyuki Tobe

Frequent Collaborators

3 joint publications

Ryuji Hayashi

1 joint publications

Shoko Matsui

1 joint publications

Akira Noguchi

1 joint publications

Tomonobu Kado

Top Related Videos

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway <em>In Vitro</em> and <em>In Vivo</em> Using an Adenovirus Reporter System

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway <em>In Vitro</em> and <em>In Vivo</em> Using an Adenovirus Reporter System

Published on : Jul 30, 2018

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

See more related videos

Top Related Videos

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway <em>In Vitro</em> and <em>In Vivo</em> Using an Adenovirus Reporter System

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway <em>In Vitro</em> and <em>In Vivo</em> Using an Adenovirus Reporter System

Published on : Jul 30, 2018

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on : Feb 12, 2017

See more related videos